|
10.05.2022 18:25:06
|
Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion deal
|
HBM Healthcare Investments AG
/ Key word(s): Acquisition
HBM Healthcare Investments today announces that its portfolio company Biohaven Pharmaceuticals (NYSE: BHVN) will be acquired by Pfizer (NYSE: PFE) for USD 11.6 billion in cash. The acquisition price of USD 148.50 per Biohaven share represents a premium of approximately 78 percent to the closing share price on 9 May 2022. Biohaven shareholders will also receive shares in "New Biohaven", a new publicly traded company that will retain Biohaven's non-CGRP pipeline compounds in development. HBM Healthcare Investments holds around 0.45 million shares in Biohaven with a total value of USD 67 million based on the acquisition price. Following the acquisition of Sierra Oncology by GlaxoSmithKline in April and of Zogenix by UCB in January, this is the third acquisition from HBM Healthcare Investments' portfolio of listed companies in the current calendar year 2022. Contact
End of Media Release |
| Language: | English |
| Company: | HBM Healthcare Investments AG |
| Bundesplatz 1 | |
| 6300 Zug | |
| Switzerland | |
| Phone: | +41438887171 |
| Fax: | +41438887172 |
| E-mail: | info@hbmhealthcare.com |
| Internet: | https://www.hbmhealthcare.com |
| ISIN: | CH0012627250 |
| Valor: | 1262725 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1348797 |
| End of News | EQS News Service |
|
|
1348797 10.05.2022
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu HBM Healthcare Investments AGmehr Nachrichten
|
18.12.24 |
Successful IPO of HBM portfolio company Sai Life Sciences on the Indian stock exchanges NSE and BSE increases NAV per HBM share by 3.2 percent (EQS Group) | |
|
18.12.24 |
Erfolgreicher Börsengang des HBM-Portfoliounternehmens Sai Life Sciences an den indischen Börsen NSE und BSE erhöht NAV pro HBM-Aktie um 3.2 Prozent (EQS Group) | |
|
16.12.24 |
Key Figures 15.12.2024 (EQS Group) | |
|
02.12.24 |
Key Figures 30.11.2024 (EQS Group) | |
|
18.11.24 |
Key Figures 15.11.2024 (EQS Group) | |
|
04.11.24 |
Key Figures 31.10.2024 (EQS Group) | |
|
21.10.24 |
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2024 with key figures for the first six months of the 2024/2025 financial year (EQS Group) | |
|
21.10.24 |
HBM Healthcare Investments publiziert Halbjahresbericht per 30. September 2024 mit Kennzahlen für die ersten sechs Monate des Geschäftsjahrs 2024/2025 (EQS Group) |
Analysen zu HBM Healthcare Investments AGmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.